Literature DB >> 8916751

Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.

M C Walker1, L M Li, J W Sander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916751      PMCID: PMC2352496          DOI: 10.1136/bmj.313.7066.1184

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy.

Authors:  J W Sander; P C Trevisol-Bittencourt; Y M Hart; P N Patsalos; S D Shorvon
Journal:  Epilepsy Res       Date:  1990-12       Impact factor: 3.045

2.  Mortality in patients with epilepsy: a study of patients in long term residential care.

Authors:  P Klenerman; J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

3.  Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre.

Authors:  L Nashef; D R Fish; J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

  3 in total
  6 in total

1.  The need for pharmacoeconomic evaluations in the NHS.

Authors:  J P Griffin
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

2.  Drug trials in epilepsy.

Authors:  G Mignot
Journal:  BMJ       Date:  1996-11-09

3.  Newly licensed drugs.

Authors:  R E Ferner
Journal:  BMJ       Date:  1996-11-09

4.  Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic.

Authors:  M W Kellett; D F Smith; P A Stockton; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

5.  Dropout rates with olanzapine or risperidone: a multi-centre observational study.

Authors:  F Pelagotti; B Santarlasci; F Vacca; S Trippoli; A Messori
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

Review 6.  The promise of new antiepileptic drugs.

Authors:  John S Duncan
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.